We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$362M
AUM Growth
+$43.1M
Cap. Flow
+$14.4M
Cap. Flow %
3.97%
Top 10 Hldgs %
36.16%
Holding
98
New
2
Increased
28
Reduced
18
Closed
–

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$7.64M
2
EXEL icon
Exelixis
EXEL
+$3.58M
3
MPLX icon
MPLX
MPLX
+$2.9M
4
EPD icon
Enterprise Products Partners
EPD
+$2.73M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$1.05M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$10M
2
FLEX icon
Flex
FLEX
+$135K
3
LBRDK
Liberty Broadband Class C
LBRDK
+$105K
4
TSLA icon
Tesla
TSLA
+$60.6K
5
LBRDA
Liberty Broadband Class A
LBRDA
+$41.1K

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 16.53%
3 Communication Services 15.06%
4 Industrials 8.7%
5 Energy 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$30.6M 8.46%
285,549
-100,000
-26% -$10M
AAPL icon
2
Apple
AAPL
$4.67T
$17.3M 4.77%
306,296
+4,724
+2% +$246K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$14.1M 3.9%
233,820
+6,060
+3% +$367K
BX icon
4
Blackstone
BX
$107B
$11.1M 3.05%
290,500
+1,840
+0.6% +$66.5K
EPD icon
5
Enterprise Products Partners
EPD
$84.3B
$9.98M 2.75%
347,326
+94,379
+37% +$2.73M
V icon
6
Visa
V
$712B
$9.84M 2.72%
65,546
+413
+0.6% +$58.7K
IBB icon
7
iShares Biotechnology ETF
IBB
$10.5B
$9.81M 2.71%
80,481
+724
+0.9% +$85.3K
CI icon
8
Cigna
CI
$73.7B
$9.81M 2.71%
47,119
+677
+1% +$126K
TMO icon
9
Thermo Fisher Scientific
TMO
$230B
$9.52M 2.63%
38,990
+252
+0.7% +$58K
UNH icon
10
UnitedHealth
UNH
$353B
$8.94M 2.47%
33,607
-25
-0.1% -$6.5K
META icon
11
Meta Platforms (Facebook)
META
$1.47T
$8.51M 2.35%
51,730
+312
+0.6% +$56.5K
MPLX icon
12
MPLX
MPLX
$60.1B
$8.38M 2.31%
241,542
+80,901
+50% +$2.9M
ADBE icon
13
Adobe
ADBE
$116B
$8.33M 2.3%
30,869
-45
-0.1% -$11.6K
CSCO icon
14
Cisco
CSCO
$433B
$8.27M 2.28%
169,991
+13,291
+8% +$598K
RTN
15
DELISTED
Raytheon Company
RTN
$8.22M 2.27%
39,798
+365
+0.9% +$72.7K
KPTI icon
16
Karyopharm Therapeutics
KPTI
$42.4M
$8.07M 2.23%
31,593
+3,800
+14% +$1.05M
PARA
17
DELISTED
Paramount Global Class B
PARA
$7.96M 2.2%
138,650
-300
-0.2% -$16.6K
AMGN icon
18
Amgen
AMGN
$234B
$7.92M 2.19%
38,187
+878
+2% +$173K
INTC icon
19
Intel
INTC
$473B
$7.81M 2.16%
165,135
+9,219
+6% +$449K
PFE icon
20
Pfizer
PFE
$159B
$7.62M 2.1%
182,144
+808
+0.4% +$31.1K
DD icon
21
DuPont de Nemours
DD
$18.5B
$7.46M 2.06%
45,801
+44,435
+3,253% +$7.64M
SYK icon
22
Stryker
SYK
$127B
$7.41M 2.05%
41,720
+285
+0.7% +$48.7K
CMCSA icon
23
Comcast
CMCSA
$96B
$7.23M 2%
204,132
+8,189
+4% +$290K
UNP icon
24
Union Pacific
UNP
$183B
$7.15M 1.97%
43,920
– –
IBM icon
25
IBM
IBM
$222B
$7.11M 1.96%
49,171
+1,630
+3% +$228K
1
2 3 4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Private Capital Advisors held 98 positions worth $362M, up 14% from $319M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Private Capital Advisors deployed $14.4M of net new capital in Q3 2018, opening 2 new positions and adding to 28 existing holdings. Its largest new stake was Exelixis: 183,350 shares worth $3.25M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Eli Lilly, an estimated $10M trimmed.

  • Private Capital Advisors's largest Q3 2018 buy was Exelixis: 183,350 shares worth $3.25M.
  • Private Capital Advisors added most to DuPont de Nemours in Q3 2018, an estimated $7.64M increase.
  • Private Capital Advisors's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $10M.
  • Private Capital Advisors's ten largest holdings make up 36% of its $362M portfolio in Q3 2018.
  • Private Capital Advisors opened 2 new positions and closed 0 in Q3 2018.
  • Private Capital Advisors's portfolio value rose 14% quarter-over-quarter to $362M.

Based on Private Capital Advisors's 13F filing for Q3 2018, filed 12 Oct 2018.